PMID: 3755645Oct 1, 1986Paper

Recent results of multimodal therapy of gastric lymphoma

Cancer
M H ShiuB J Lee

Abstract

The efficacy of multimodality treatment of gastric lymphoma was examined in a retrospective study of 46 patients treated at the Memorial Sloan-Kettering Cancer Center from 1971 to 1982. The principal treatment plan consisted of surgical resection of the gastric lymphoma (n = 36) where feasible, followed by radiation therapy of the whole abdomen (n = 23) with a boosting dose to the stomach-bed to 3700 cGy, and/or chemotherapy using mainly the CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) regimen as an adjuvant (n = 7), or CHOP plus other drugs for advanced disease. The median follow-up time of patients was 61 months (range, 30 months to 14 years). There was no operative mortality. No patient developed known relapse in the abdomen after resection and total abdominal irradiation, and none suffered relapses after adjuvant chemotherapy, for Stages I-E and II-E. At 5 years, the estimated survival rate after treatment was 95%, 78%, and 25%, respectively for Stages I-E (n = 20), II-E (n = 9) and IV (n = 17). The results for Stage I-E and II-E resectable tumors were significantly improved (P less than 0.05 and less than 0.1 respectively) over those of similar tumors treated in 1949 to 1970.

References

Apr 1, 1977·Cancer·F E LimW A Meissner
Apr 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W P SheridanG N Brodie
Nov 1, 1974·Gastrointestinal Endoscopy·R S Nelson, F L Lanza
Sep 1, 1973·Cancer·S E JonesS A Rosenberg
Jan 1, 1974·American Journal of Surgery·J Connors, L Wise
May 1, 1973·The American Journal of Digestive Diseases·S KatzP Sherlock
May 1, 1969·Radiology·R S Bush, C L Ash
Jan 1, 1983·International Journal of Radiation Oncology, Biology, Physics·M K GospodarowiczT Chua
Jun 1, 1983·The American Journal of Surgical Pathology·D A FilippaS S Bretsky
Feb 1, 1982·Annals of Surgery·M H ShiuP H Lieberman
Mar 15, 1982·Cancer·D N WeingradD A Filippa
Jan 1, 1960·The British Journal of Surgery·J G AZZOPARDI, T MENZIES

❮ Previous
Next ❯

Citations

Mar 1, 1996·Journal of Surgical Oncology·M M LawJ H Wong
May 1, 1995·Hematological Oncology·R LiangF C Ho
Nov 1, 1993·Journal of Surgical Oncology·G B SeccoG Nicolò
Oct 1, 1994·Journal of Surgical Oncology·R Ben-Yosef, R T Hoppe
Sep 1, 1995·Journal of Surgical Oncology·R R ChandranH K Chaturvedi
Jan 1, 1990·Seminars in Surgical Oncology·A SolidoroJ A Montalbetti
Jan 1, 1991·Cancer Chemotherapy and Pharmacology·R LiangS L Loke
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·N A WillichP Koch
Mar 22, 2000·International Journal of Radiation Oncology, Biology, Physics·N R Schechter, J Yahalom
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A PopescuM E Hill
Jan 1, 1996·Annals of Surgery·D L BartlettM F Brennan
Jan 1, 1991·Leukemia & Lymphoma·G Varsos, J Yahalom
Jan 1, 1991·Scandinavian Journal of Gastroenterology. Supplement·B G Taal, J M Burgers
Mar 4, 2005·Journal of the Chinese Medical Association : JCMA·Ching-Liang HoTsu-Yi Chao
Mar 8, 2006·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ming-Chih ChangRuey-Kuen Hsieh
Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·M K GospodarowiczR S Bush
Oct 20, 1993·International Journal of Radiation Oncology, Biology, Physics·R K ValicentiN A Kucik
Apr 7, 2009·Journal of Surgical Oncology·Kourosh SarkhoshLloyd A Mack
Jan 1, 1991·American Journal of Surgery·H V VillarC Spier
Apr 1, 1994·Surgical Oncology·D H RoukosD Casioumis
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A Rossi, T A Lister
Jan 1, 1992·Critical Reviews in Oncology/hematology·M R MirzaL Specht
Mar 1, 1989·European Journal of Cancer & Clinical Oncology·B G TaalT L Tio
Dec 1, 1996·Baillière's Clinical Haematology·E Zucca, F Cavalli
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F PasiniG L Cetto
Oct 15, 1987·Cancer·J A StrauchenM Greenberg
Nov 1, 1994·World Journal of Surgery·Y TanakaK Koto
Jan 11, 1991·Medical and Pediatric Oncology·C R Thomas, R Share

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.